vs

Side-by-side financial comparison of AMC Networks Inc. (AMCX) and Penumbra Inc (PEN). Click either name above to swap in a different company.

AMC Networks Inc. is the larger business by last-quarter revenue ($594.8M vs $385.4M, roughly 1.5× Penumbra Inc). Penumbra Inc runs the higher net margin — 12.3% vs -9.3%, a 21.6% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs -0.8%). Penumbra Inc produced more free cash flow last quarter ($68.0M vs $40.4M). Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs -0.1%).

AMC Networks Inc. is an American independent mass media and entertainment corporation headquartered in 11 Penn Plaza, New York City. The company owns and operates the eponymous cable channel, BBC America, IFC, Sundance TV, and We TV. It also owns the art house movie theater IFC Center in New York City; the independent film companies Independent Film Company and RLJE Films, the anime licensor Sentai Filmworks, the premium subscription streaming services AMC+, IFC Films Unlimited, Acorn TV, All...

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

AMCX vs PEN — Head-to-Head

Bigger by revenue
AMCX
AMCX
1.5× larger
AMCX
$594.8M
$385.4M
PEN
Growing faster (revenue YoY)
PEN
PEN
+22.9% gap
PEN
22.1%
-0.8%
AMCX
Higher net margin
PEN
PEN
21.6% more per $
PEN
12.3%
-9.3%
AMCX
More free cash flow
PEN
PEN
$27.6M more FCF
PEN
$68.0M
$40.4M
AMCX
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
-0.1%
AMCX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMCX
AMCX
PEN
PEN
Revenue
$594.8M
$385.4M
Net Profit
$-55.5M
$47.3M
Gross Margin
49.7%
68.0%
Operating Margin
-8.6%
15.4%
Net Margin
-9.3%
12.3%
Revenue YoY
-0.8%
22.1%
Net Profit YoY
80.5%
40.6%
EPS (diluted)
$-0.97
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMCX
AMCX
PEN
PEN
Q4 25
$594.8M
$385.4M
Q3 25
$561.7M
$354.7M
Q2 25
$600.0M
$339.5M
Q1 25
$555.2M
$324.1M
Q4 24
$599.3M
$315.5M
Q3 24
$599.6M
$301.0M
Q2 24
$625.9M
$299.4M
Q1 24
$596.5M
$278.7M
Net Profit
AMCX
AMCX
PEN
PEN
Q4 25
$-55.5M
$47.3M
Q3 25
$76.5M
$45.9M
Q2 25
$50.3M
$45.3M
Q1 25
$18.0M
$39.2M
Q4 24
$-284.5M
$33.7M
Q3 24
$41.4M
$29.5M
Q2 24
$-29.2M
$-60.2M
Q1 24
$45.8M
$11.0M
Gross Margin
AMCX
AMCX
PEN
PEN
Q4 25
49.7%
68.0%
Q3 25
48.2%
67.8%
Q2 25
52.7%
66.0%
Q1 25
51.8%
66.6%
Q4 24
51.2%
66.8%
Q3 24
52.0%
66.5%
Q2 24
55.2%
54.4%
Q1 24
54.5%
65.0%
Operating Margin
AMCX
AMCX
PEN
PEN
Q4 25
-8.6%
15.4%
Q3 25
9.9%
13.8%
Q2 25
10.7%
12.0%
Q1 25
11.6%
12.4%
Q4 24
-42.4%
13.6%
Q3 24
15.6%
11.7%
Q2 24
1.7%
-27.0%
Q1 24
18.5%
4.3%
Net Margin
AMCX
AMCX
PEN
PEN
Q4 25
-9.3%
12.3%
Q3 25
13.6%
12.9%
Q2 25
8.4%
13.3%
Q1 25
3.3%
12.1%
Q4 24
-47.5%
10.7%
Q3 24
6.9%
9.8%
Q2 24
-4.7%
-20.1%
Q1 24
7.7%
3.9%
EPS (diluted)
AMCX
AMCX
PEN
PEN
Q4 25
$-0.97
$1.20
Q3 25
$1.38
$1.17
Q2 25
$0.91
$1.15
Q1 25
$0.34
$1.00
Q4 24
$-6.23
$0.88
Q3 24
$0.76
$0.75
Q2 24
$-0.66
$-1.55
Q1 24
$1.03
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMCX
AMCX
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$502.4M
$186.9M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$981.9M
$1.4B
Total Assets
$3.9B
$1.8B
Debt / EquityLower = less leverage
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMCX
AMCX
PEN
PEN
Q4 25
$502.4M
$186.9M
Q3 25
$716.8M
$321.0M
Q2 25
$866.4M
$421.8M
Q1 25
$870.2M
$376.1M
Q4 24
$784.6M
$324.4M
Q3 24
$816.4M
$280.5M
Q2 24
$802.6M
$288.3M
Q1 24
$690.5M
$223.1M
Total Debt
AMCX
AMCX
PEN
PEN
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$2.2B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.4B
Q1 24
$2.3B
Stockholders' Equity
AMCX
AMCX
PEN
PEN
Q4 25
$981.9M
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$971.7M
$1.3B
Q1 25
$888.8M
$1.2B
Q4 24
$855.6M
$1.2B
Q3 24
$1.1B
$1.1B
Q2 24
$1.1B
$1.2B
Q1 24
$1.1B
$1.2B
Total Assets
AMCX
AMCX
PEN
PEN
Q4 25
$3.9B
$1.8B
Q3 25
$4.2B
$1.7B
Q2 25
$4.4B
$1.7B
Q1 25
$4.3B
$1.6B
Q4 24
$4.4B
$1.5B
Q3 24
$4.8B
$1.5B
Q2 24
$4.9B
$1.5B
Q1 24
$4.9B
$1.6B
Debt / Equity
AMCX
AMCX
PEN
PEN
Q4 25
1.78×
Q3 25
1.82×
Q2 25
2.27×
Q1 25
2.62×
Q4 24
2.73×
Q3 24
2.10×
Q2 24
2.26×
Q1 24
2.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMCX
AMCX
PEN
PEN
Operating Cash FlowLast quarter
$49.2M
$86.5M
Free Cash FlowOCF − Capex
$40.4M
$68.0M
FCF MarginFCF / Revenue
6.8%
17.7%
Capex IntensityCapex / Revenue
1.5%
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$272.4M
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMCX
AMCX
PEN
PEN
Q4 25
$49.2M
$86.5M
Q3 25
$44.8M
$58.3M
Q2 25
$102.8M
$44.9M
Q1 25
$108.8M
$49.0M
Q4 24
$58.1M
$51.1M
Q3 24
$62.2M
$56.5M
Q2 24
$104.4M
$22.6M
Q1 24
$150.9M
$38.3M
Free Cash Flow
AMCX
AMCX
PEN
PEN
Q4 25
$40.4M
$68.0M
Q3 25
$42.0M
$42.0M
Q2 25
$95.7M
$29.4M
Q1 25
$94.2M
$35.5M
Q4 24
$37.6M
$45.7M
Q3 24
$53.9M
$51.0M
Q2 24
$95.2M
$18.1M
Q1 24
$144.1M
$32.5M
FCF Margin
AMCX
AMCX
PEN
PEN
Q4 25
6.8%
17.7%
Q3 25
7.5%
11.8%
Q2 25
16.0%
8.7%
Q1 25
17.0%
11.0%
Q4 24
6.3%
14.5%
Q3 24
9.0%
16.9%
Q2 24
15.2%
6.0%
Q1 24
24.2%
11.7%
Capex Intensity
AMCX
AMCX
PEN
PEN
Q4 25
1.5%
4.8%
Q3 25
0.5%
4.6%
Q2 25
1.2%
4.6%
Q1 25
2.6%
4.2%
Q4 24
3.4%
1.7%
Q3 24
1.4%
1.8%
Q2 24
1.5%
1.5%
Q1 24
1.1%
2.1%
Cash Conversion
AMCX
AMCX
PEN
PEN
Q4 25
1.83×
Q3 25
0.59×
1.27×
Q2 25
2.04×
0.99×
Q1 25
6.03×
1.25×
Q4 24
1.52×
Q3 24
1.50×
1.91×
Q2 24
Q1 24
3.29×
3.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMCX
AMCX

Subscription And Circulation$314.8M53%
Advertising$124.9M21%
Other$79.1M13%
License$74.8M13%
Related Party$1.2M0%

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons